The relationship between age and production of tumour necrosis factor-α in healthy volunteers and patients with chronic heart failure

International Journal of Cardiology

Volumn 90, Issue 2-3, 2003, Pages 197-204

  Von Haehling, Stephan ^a,b   Genth Zotz, Sabine ^a,c   Sharma, Rakesh ^a   Bolger, Aidan P ^a   Doehner, Wolfram ^a   Barnes, Peter J ^a   Coats, Andrew J S ^a   Anker, Stefan D ^a,b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b Franz Volhard Klinik   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Ageing; Endotoxin; Heart failure; Immune system; Tumour necrosis factor

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE; AGED; AGING; ANALYSIS OF VARIANCE; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; FEMALE; HEART FAILURE; HUMAN; HUMAN CELL; IMMUNE SYSTEM; MALE; MONONUCLEAR CELL; OUTCOMES RESEARCH; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 0042885542     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(02)00566-1     Document Type: Article

References (23)

1. Castle S.C. Impact of age-related immune dysfunction on risk of infections. Z Gerontol Geriat. 33:2000;341-349.
2. Bruunsgaard H., Pedersen A.N., Schroll M., Skinhoj P., Pedersen B.K. Impaired production of proinflammatory cytokines in response to lipopolysaccharide (LPS) stimulation in elderly humans. Clin Exp Immunol. 118:1999;235-241.
3. Delpedro A.D., Barjavel M.J., Mamdouh Z., Faure S., Bakouche O. Signal transduction in LPS-activated aged and young monocytes. J Interferon Cytokine Res. 18:1998;429-437.
4. Fagiolo U., Cossarizza A., Scala E., Fanales-Belasio E., Ortolani C., Cozzi E., et al. Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol. 23:1993;2375-2378.
5. Riancho J.A., Zarrabeitia M.T., Amado J.A., Olmos J.M., Gonzalez-Macias J. Age-related differences in cytokine secretion. Gerontology. 40:1994;8-12.
6. Bolger A.P., Anker S.D. Tumour necrosis factor in chronic heart failure: a peripheral view on pathogenesis, clinical manifestations and therapeutic implications. Drugs. 60:2000;1245-1257.
7. Levine B., Kalman J., Mayer L., Fillit H.M., Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 323:1990;236-241.
8. Deswal A., Petersen N.J., Feldman A.M., Young J.B., White B.G., Mann D.L. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the vesnarinone trial (VEST). Circulation. 103:2001;2055-2059.
9. Rauchhaus M., Doehner W., Francis D.P., Davos C., Kemp M., Liebenthal C., et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation. 102:2000;3060-3067.
10. Anker S.D., Egerer K.R., Volk H.D., Kox W.J., Poole-Wilson P.A., Coats A.J.S. Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol. 79:1997;1426-1430.
11. Niebauer J., Volk H.D., Kemp M., Dominguez M., Schumann R.R., Rauchhaus M., et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet. 353:1999;1838-1842.
12. Yokota M., Kambayashi J., Tanaka T., Tsujinaka T., Sakon M., Mori T. A simple turbidimetric time assay of the endotoxin in plasma. J Biochem Biophys Methods. 18:1989;97-104.
13. Genth-Zotz S., von Hoehling S., Bolger A.P., Kalra P.R., Wensel R., Coats A.J., Anker S.D. Pathophysio logic quantities of endotoxin-induced tmor necrosis factor-alpha release in whole blood from patients with chronic heart failure. Am J Cardiol. 90:2002;1226-1230.
14. Rauchhaus M., Haehling von Lanzenauer S., Coats A.J.S. Nitric oxide synthase in CHF (letter). Eur Heart J. 21:2000;856-857.
15. Kendall M.J. Hypertension in the elderly. Basic Res Cardiol. 93:(Suppl 2):1998;43-46.
16. Lakatta E.G. Myocardial adaptations in advanced age. Basic Res Cardiol. 88:(Suppl 2):1993;125-133.
17. Lehtonen L., Eskola J., Vainio O., Lehtonen A. Changes in lymphocyte subsets and immune competence in very advanced age. J Gerontol. 45:1990;M108-M112.
18. Rink L., Cakman I., Kirchner H. Altered cytokine production in the elderly. Mech Ageing Dev. 102:1998;199-209.
19. Paganelli R., Quinti I., Fagiolo U., Cossarizza A., Ortolani C., Guerra E., et al. Changes in circulating B cells and immunoglobulin classes and subclasses in a healthy aged population. Clin Exp Immunol. 90:1992;351-354.
20. Torre-Amione G., Kapadia S., Benedict C., Oral H., Young J.B., Mann D.L. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol. 27:1996;1201-1206.
21. Anker S.D., Chua T.P., Ponikowski P., Harrington D., Swan J.W., Kox W.J., et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation. 96:1997;526-534.
22. von Haehling S., Genth-Zotz S., Anker S.D., Volk H.D. Cachexia: a therapeutic approach beyond cytokine antagonism. Int J Cardiol. 85:2002;173-183.
23. Rauchhaus M., Coats A.J.S., Anker S.D. The endotoxin-lipoprotein hypothesis. Lancet. 356:2000;930-933.